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Abstract: The synthesis of hydroxamic acids starting from carbox-
ylic acids employing 1-propanephosphonic acid cyclic anhydride
(T3P) activation is described. Application of ultrasonication accel-
erates this conversion. Further, the T3P has also been employed to
activate the hydroxamates, leading to isocyanates via the Lossen re-
arrangement. The isocyanates were trapped with suitable nucleo-
philes to afford the corresponding ureas and carbamates.
Key words: T3P, hydroxamic acids, Lossen rearrangement, isocy-
anates
Functional group transformation has acquired a signifi-
cant place in organic chemistry. Among a plethora of in-
termediates described, isocyanates1 have been one of the
outstanding discoveries due to their vast application in
synthetic as well as biological studies.2,3 Consequently,
there has been significant interest in the development of
new and simpler protocols for the preparation of isocyan-
ates.
Classical Curtius rearrangement of acyl azides is a well-
known reaction for the synthesis of isocyanates.4 Activat-
ed carboxylic acids in the form of acid chlorides or mixed
anhydrides are subjected to azidolysis or the carboxylic
acids are directly converted into acyl azides employing
azide-transfer reagents and then the acyl azides are rear-
ranged under thermal conditions.5–9 Although decent
yields are obtained, multistep sequences, the cost of some
of the reagents and the potentially explosive nature of acid
azides limit this method mainly to bench-scale prepara-
tions. Isocyanates can also be accessed via the Hofmann
rearrangement, which involves oxidant-mediated conver-
sion of an amide into isocyanate.10 This protocol requires
a large excess of base and hence is not compatible with
amino acid chemistry considering the epimerization prob-
lems.
The Lossen rearrangement (LR), which describes the
transformation of activated hydroxamic acids into isocy-
anates, is a valid alternative for an easy access to isocyan-
ates.4 Reagents such as p-toluenesulfonyl chloride,11
cyanuric chloride,12 1,1¢-carbonyldiimidazole,13 acylating
agents,14 N,N¢-dicyclohexylcarbodiimide15 and N-benzyl-
N¢-(3-dimethylaminopropyl)carbodiimide16 have been
utilized to bring about this transformation. Recently, we
reported a facile LR of Na-urethane-protected amino acid
hydroxamates into isocyanates employing N-ethyl-N¢-(3-
dimethylaminopropyl)carbodiimide hydrochloride.17 The
LR of preactivated hydroxamic acids is also known.18a A
common drawback posed by several methods, however, is
the accumulation of isocyanate before the complete acti-
vation of hydroxamic acid leading to self-condensed
byproduct.18b Such complexities of existing protocols
warrant a facile activation of hydroxamic acids leading to
isocyanates.
1-Propanephosphonic acid cyclic anhydride (T3P) is one
of the economic and efficient coupling agents and is also
a water scavenger. Advantages such as high-yielding re-
actions, broad functional group tolerance, low epimeriza-
tion and easy workup procedures make the reagent
meritorious over several contemporaries. The byproducts
are water soluble and eliminate the need for chromato-
graphic purification. Applications of T3P in the synthesis
of peptides,19 Weinreb amides and nitriles are well docu-
mented.20–24 We reasoned that T3P, being a carboxy acti-
vator, can be employed for the preparation of
hydroxamates from the corresponding acids and, being a
dehydrating agent, could be a suitable promoter for the LR
via O-activation. To the best of our knowledge, except for
a couple of examples of the LR of benzoic acid hydroxam-
ates to Boc/Z-protected anilines,25 a meticulous study on
the T3P-mediated LR for the conversion of hydroxamates
into isocyanates is yet to be reported. We herein describe
the T3P-promoted LR of hydroxamates derived from aro-
matic acids, as well as Na-protected amino acids, into iso-
cyanates and conversion of the latter into urea, carbamate
and thiocarbamate derivatives (Scheme 1).
Hydroxamic acids are valuable compounds for their phar-
macokinetic merits as well as their synthetic utility.26,27
Reaction of hydroxylamine with activated carboxylic acid
derivatives (such as acid chlorides, mixed anhydrides, ox-
azolidinones, esters)28,29 is employed for their preparation.
They have also been obtained starting from aldehydes by
employing the Angeli–Riminis reaction on a solid sup-
port.30a Hypervalent iodine(III) mediated oxidation of al-
doximes has also been demonstrated.30b T3P is a superior,
traceless and environmentally benign promoter for N-acy-
lation. Appendino’s group reported a 12-hour reaction
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Scheme 1 Synthesis of hydroxamates and urea/carbamate derivatives
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Table 1 Hydroxamates 2 and Urea/Carbamate Derivatives 3
Entry R1CONHOH 2, 
Yield (%)
HRMS [M + Na]+
obsd (calcd)
Mp 
(°C)
R1NHCOXR2 3, 
Yield (%)
HRMS [M + Na]+
obsd (calcd)
Mp 
(°C)
1
2a, 88
174.0535
(174.0531) waxy solid
30a 3a, 85
3b, 75
283.0619
(283.0614)
272.1091
(272.1085)
gum38a
gum
2
2b, 86
205.01a
(205.02) 135–137
3c, 86
3d, 75
294.0849
(294.0855)
233.07a
(233.05)
187–188
(188)38a
92–93
(93)38a
3
2c, 85
165.9944
(165.9939)
122–123
(122–123)30a
3e, 89
318.9511
(318.9517)
244
(245)38a
4
2d, 89
128.0341b
(128.0348) 120–121
3f, 91
219.0751
(219.0746) 176
5
2e, 85
160.0368
(160.0374)
125–127
(126–127)30a
3g, 84
250.09a
(250.08) 188
6
2f, 83
237.9486
(237.9480)
184–185
(184–185)30b
3h, 79
327.9941
(327.9949) 167
a
 ESI-MS.
b
 [M + H]+.
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protocol for the T3P-mediated synthesis of hydroxamic
acids at room temperature.31 With our previous experi-
ence and published work on ultrasound-accelerated reac-
tions,32 we reasoned that ultrasonic waves may hasten this
process and render the formation of hydroxamic acids
from the corresponding carboxylic acids in a shorter dura-
tion of time. Practically, this was the case and we could re-
duce the reaction time from 12 hours to 60 minutes under
ultrasonication. Initially, a solution of p-nitrobenzoic acid
and an equimolar quantity of T3P in acetonitrile in the
presence of N-methylmorpholine (NMM) was stirred at
0 °C to facilitate activation. After 15 minutes, hydroxyl-
amine was added and the reaction was run under ultra-
sonication for another 30 minutes to allow for the
completion of the reaction (Scheme 1). A simple workup
led to the isolation of N-hydroxy-4-nitrobenzamide (2b)
in good yield (86%); a single recrystallization from tet-
rahydrofuran–hexane gave analytically pure sample as a
crystalline solid (Table 1, entry 2). Five more hydroxamic
acids, 2a, 2c–f, were also made in a similar way, starting
from phenylacetic acid, 2-thiophenic acid, 2-furoic acid,
benzoic acid and p-bromobenzoic acid (Table 1, entries 1,
3–6).
Further, the protocol was extended to the preparation of a
series of Na-protected amino acid hydroxamates 4
(Table 2). Several procedures have been reported33 for
such compounds, including a one-pot preparation em-
ploying cyanuric chloride in the presence of 4-(dimethyl-
amino)pyridine.34 Mordini and co-workers demonstrated
the microwave-assisted transformation of N-protected
amino acid esters into the corresponding hydroxamic
acids.35 Previously, we have reported the magnesium ox-
ide mediated synthesis of Na-Fmoc-protected amino acid
hydroxamates employing the corresponding acid chlo-
rides;36 however, due to the instability of the acid chlo-
rides, the protocol could not be extended to N-Boc or Z-
protected amino acids. To develop a common and mild
protocol for the synthesis of hydroxamates compatible
with all three of the common urethane-protected amino
acids (Fmoc, Boc, Z), we began our study with a Na-Boc-
protected amino acid. Thus, a solution of Na-Boc-Phe-OH
in acetonitrile in the presence of NMM was treated with
T3P at 0 °C for 15 minutes. After the addition of hydrox-
ylamine, the mixture was subjected to ultrasonication.
Satisfactorily, the reaction proceeded smoothly and was
complete in about 90 minutes, to yield Na-Boc-Phe-
NHOH (4h) in 89% yield. Similarly, Fmoc- and Z-pro-
tected a-amino acids were also converted into their corre-
sponding hydroxamates 4 (Table 2).
In the next stage, the LR of the hydroxamates, mediated
by T3P, was carried out. A chilled solution of hydroxam-
ate 2b and T3P in tetrahydrofuran in the presence of
NMM was stirred for about 30 minutes. After the comple-
tion of O-activation of the hydroxamate (TLC analysis),
the mixture was refluxed for 1.5 hours. The IR spectrum
of the reaction mixture showed a strong peak at 2240 cm–1,
corresponding to the isocyanate. The O-activation of hy-
droxamic acids takes a longer time than that required for
carboxy activation during the preparation of hydroxam-
ates, and an excess of T3P is required to drive the reaction
towards completion. After confirming the formation of
isocyanates, our next objective was to trap them with nu-
cleophiles such as amines, alcohols and thiols. Towards
this end, typically, after stirring a solution of hydroxamate
2b along with T3P and NMM in tetrahydrofuran at 0 °C
for 30 minutes, the reaction mixture was refluxed in the
presence of a nucleophile such as p-methylaniline. After
completion of the reaction (3 h), a simple workup led to
Table 2 N-Urethane-Protected Amino Acid Hydroxamates 4
Hydroxamate 4 PG-Xaa-NHOH Reaction time (min) Yield (%) Mp (°C)
PG Xaa
4a Fmoc Ala 90 97 128
(128)36
4b Fmoc Phe 80 93 151–152
(150–152)34
4c Fmoc Glu(Ot-Bu) 85 95 132–133
(131–133)17
4d Fmoc Ser(OBn) 110 93 163–164
(164)36
4e Fmoc Phg 80 84 132–133
(132)36
4f Z Ala 90 91 oil
4g Z Phg 90 92 160
(159–161)17
4h Boc Phe 90 89 oil
4i Boc Glu(OBn) 110 79 81–82
(82–83)34
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the isolation of urea 3c in 86% yield (Table 1, entry 2).
The generality of this reaction was confirmed by the syn-
thesis of ureas 3a, 3e, 3f, carbamates 3d, 3g, 3h, and thio-
carbamate 3b (see Scheme 1 and Table 1).
Finally, the utility of this protocol for the preparation of
peptidomimetics was studied. To a chilled solution of Na-
Boc-Phe-NHOH (4h) in tetrahydrofuran, T3P and NMM
were added, and the mixture was stirred for 30 minutes.
Then, after adding H2N-Val-OMe (obtained by deproto-
nation of the corresponding hydrochloride salt using Zn
dust37), the mixture was refluxed for two hours to obtain
the ureidopeptide, albeit in low yield. The not-so-encour-
aging result obtained using the thermal method led us to
test the feasibility of this transformation under ultrasoni-
cation. To our delight, when the reaction mixture, after the
O-activation step, was subjected to ultrasonication, the ac-
tivated hydroxamic acid underwent the LR and the isocy-
anate formed in situ reacted with the amine to afford urea
5c in a shorter duration (an hour) in good yield (85%)
(Scheme 2 and Table 3). A few Boc- and Z-protected a-
amino acid hydroxamates were subjected to the LR and
the corresponding ureas 5c–e were isolated as analytically
pure products (Table 3). Fmoc-Protected ureidopeptides
precipitated as solids from the reaction mixture and a sin-
gle recrystallization step led to crystalline products (5a
and 5b). The protocol was further extended to the prepa-
ration of a few active carbamates 6a–c derived from Na-
protected amino acids by trapping the intermediate isocy-
anates with substituted phenols (Scheme 2 and Table 3).
All products were isolated and characterized by NMR and
mass spectroscopy.
Scheme 2 Synthesis of ureidopeptides 5 and carbamates 6 by the
LR of hydroxamates 4
The protocol was revisited to check whether the method-
ology demonstrated here is free from racemization. A set
of epimeric ureidopeptides, Na-Fmoc-PhgU-L-Ala-OMe
(5f) and Na-Fmoc-PhgU-D-Ala-OMe (5g), were prepared
starting from racemization-prone Na-Fmoc-Phg-OH and
their 1H NMR spectra were examined for the methyl
group resonance of the alanyl residue. Distinct doublets
were observed at d = 1.28 and 1.30 ppm for 5f and at d =
1.29 and 1.32 ppm for 5g. This clearly indicates the pres-
ence of a single diastereomer in each sample. This, in turn,
suggests that Na-Fmoc-Phg-NHOH (4e) is epimerically
pure, and thus also the urea derivatives prepared from it
via the LR to the extent detectable by NMR analysis.
In summary, a facile conversion of aromatic acids, as well
as N-protected amino acids, into hydroxamates under ul-
trasonication using T3P as carboxy activator is described.
Further, the T3P was employed to mediate the Lossen re-
arrangement of these hydroxamates. The generated isocy-
anates were utilized to synthesize urea, carbamate and
thiocarbamate derivatives.
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Table 3 Ureidopeptides 5 and Active Carbamates 6
Urea 5/Carbamate 6 Yield (%) Mp (°C)
5a
96 180(181)38a
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84 140–141(140)5a
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All solvents were distilled prior to use and reagents were used as re-
ceived from Sigma-Aldrich. Melting points were determined on a
Buchi model 150 melting point apparatus in open capillaries and are
uncorrected. IR spectra were recorded on a Nicolet Impact model
400D FT-IR spectrometer (KBr pellets, 3 cm–1 resolution). 1H and
13C NMR spectra were recorded on a Bruker AMX 300-MHz spec-
trometer. High-resolution mass spectra were recorded on a Micro-
mass Q-TOF mass spectrometer.
Hydroxamic Acids 2; General Procedure
To a chilled (0 °C) soln of an aromatic acid or a N-protected amino
acid (1 mmol) and NMM (0.12 mL, 1.1 mmol) in MeCN (10 mL)
was added 50% T3P in EtOAc (0.71 mL, 1.2 mmol). The reaction
mixture was stirred at the same temperature for 15 min and then
subjected to ultrasonication after the addition of NH2OH (83 mg,
1.2 mmol; obtained by neutralization of the corresponding hydro-
chloride salt with NMM) until the reaction was completed. The
mixture was diluted with EtOAc (15 mL), and washed with H2O and
brine. The organic phase was dried (anhyd Na2SO4), the solvent was
evaporated under reduced pressure, and the residue was recrystal-
lized (THF–hexane).
N-Hydroxy-4-nitrobenzamide (2b)
Yield: 157 mg (86%); white solid; mp 135–137 °C; Rf = 0.35
(CHCl3–MeOH, 9:1).
IR (KBr): 1642 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 7.72 (d, J = 5.4 Hz, 2 H), 7.91
(d, J = 5.4 Hz, 2 H), 8.57 (s, 1 H), 10.58 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): d = 122.8, 128.1, 139.8, 146.8,
166.8.
ESI-MS: m/z [M + Na]+ calcd for C7H6N2O4: 205.02; found: 205.01.
Anal. Calcd for C7H6N2O4: C, 46.16; H, 3.32; N, 15.38. Found: C,
46.20; H, 3.28; N, 15.47.
N-Hydroxyfuran-2-carboxamide (2d)
Yield: 113 mg (89%); white solid; mp 120–121 °C (Lit.28c 119–
122 °C); Rf = 0.40 (CHCl3–MeOH, 9:1).
IR (KBr): 1641 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 6.80 (m, 1 H), 7.21 (d, J = 6.0
Hz, 1 H), 7.23 (d, J = 6.0 Hz, 1 H), 8.89 (s, 1 H), 10.89 (br, 1 H).
13C NMR (75 MHz, DMSO-d6): d = 118.0, 121.5, 146.3, 148.8,
172.9.
HRMS: m/z [M + H]+ calcd for C5H5NO3: 128.0348; found:
128.0341.
Anal. Calcd for C5H5NO3: C, 47.25; H, 3.97; N, 11.02. Found: C,
47.32; H, 3.97; N, 11.09.
Organic Ureas/Carbamates 3; General Procedure
To a soln of a hydroxamic acid 2 (1.0 mmol) in THF (10 mL) at
0 °C, NMM (0.16 mL, 1.5 mmol) and T3P (0.89 mL, 1.5 mmol)
were added and the mixture was stirred for 30 min. Then, the nu-
cleophile (amine or alcohol, 1.5 mmol) was added and the mixture
was refluxed for 3 h. The solvent was removed under reduced pres-
sure, the residue was diluted with EtOAc (15 mL), and the organic
layer was washed with 10% HCl (10 mL), H2O (10 mL) and brine,
then dried (anhyd Na2SO4). The solvent was evaporated under re-
duced pressure to afford the product.
S-Cyclohexyl Benzylthiocarbamate (3b)
Yield: 187 mg (75%); gum; Rf = 0.50 (n-hexane–EtOAc, 7:3).
IR (KBr): 1655 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 1.28–1.46 (m, 6 H), 1.52–1.68
(m, 4 H), 4.36 (d, J = 6.2 Hz, 2 H), 5.98 (br, 1 H), 7.12–7.22 (m, 5
H).
13C NMR (75 MHz, DMSO-d6): d = 22.5, 31.1, 34.6, 46.7, 47.9,
125.6, 126.7, 127.5, 139.9, 166.7.
HRMS: m/z [M + Na]+ calcd for C14H19NOS: 272.1085; found:
272.1091.
Anal. Calcd for C14H19NOS: C, 67.43; H, 7.68; N, 5.62. Found: C,
67.48; H, 7.71; N, 5.68.
N-(Furan-2-yl)morpholine-4-carboxamide (3f)
Yield: 178 mg (91%); white solid; mp 176 °C; Rf = 0.45 (n-hexane–
EtOAc, 7:3).
IR (KBr): 1655 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 3.52 (t, J = 7.2 Hz, 4 H), 3.72
(t, J = 7.6 Hz, 4 H), 6.85 (m, 1 H), 7.21 (d, J = 6.9 Hz, 1 H), 7.43 (d,
J = 7.0 Hz, 1 H), 8.61 (br, 1 H).
13C NMR (75 MHz, DMSO-d6): d = 45.2, 66.7, 112.3, 116.8, 143.1,
145.9, 155.8.
HRMS: m/z [M + Na]+ calcd for C9H12N2O3: 219.0746; found:
219.0751.
Anal. Calcd for C9H12N2O3: C, 55.09; H, 6.16; N, 14.28. Found: C,
55.12; H, 6.13; N, 14.35.
Benzyl Phenylcarbamate (3g)
Yield: 191 mg (84%); white solid; mp 188 °C; Rf = 0.50 (n-hexane–
EtOAc, 7:3).
IR (KBr): 1738 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 5.11 (s, 2 H), 6.91 (br, 1 H),
7.21–7.65 (m, 10 H).
13C NMR (75 MHz, DMSO-d6): d = 66.4, 126.8, 127.1, 127.5,
129.1, 132.6, 133.4, 138.2, 143.1, 155.1.
ESI-MS: m/z [M + Na]+ calcd for C14H13NO2: 250.08; found:
250.09.
Anal. Calcd for C14H13NO2: C, 73.99; H, 5.77; N, 6.16. Found: C,
73.93; H, 5.81; N, 6.20.
Benzyl 4-Bromophenylcarbamate (3h)
Yield: 242 mg (79%); pale yellow solid; mp 167 °C; Rf = 0.45 (n-
hexane–EtOAc, 7:3).
IR (KBr): 1742 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 5.12 (s, 2 H), 6.31 (br, 1 H),
7.23–7.37 (m, 5 H), 7.53 (d, J = 8.2 Hz, 2 H), 7.78 (d, J = 8.4 Hz, 2
H).
13C NMR (75 MHz, DMSO-d6): d = 65.6, 121.3, 122.9, 127.2,
127.8, 128.9, 132.4, 134.9, 141.5, 155.9.
HRMS: m/z [M + Na]+ calcd for C14H12BrNO2: 327.9949; found:
327.9941.
Anal. Calcd for C14H12BrNO2: C, 54.92; H, 3.95; N, 4.58. Found: C,
54.96; H, 3.88; N, 4.58.
Ureidopeptides 5/Active Carbamates 6; General Procedure
To a soln of a N-protected amino acid hydroxamate 4 (1.0 mmol) in
THF (10 mL) at 0 °C, NMM (0.16 mL, 1.5 mmol) and T3P (0.89
mL, 1.5 mmol) were added and the reaction mixture was stirred at
0 °C for 30 min. Then, H2N-Xaa-OMe or a substituted phenol (1.2
mmol) was added and the reaction mixture was subjected to ultra-
sonication until completion (90 min, TLC analysis). Urea products
which precipitated out from the reaction mixture were collected by
filtration and recrystallized (DMSO–H2O). Otherwise, the urea or
D
ow
nl
oa
de
d 
by
: F
lo
rid
a 
In
te
rn
at
io
na
l U
ni
ve
rs
ity
. C
op
yr
ig
ht
ed
 m
at
er
ia
l.
PAPER T3P as an Efficient Promoter for the Lossen Rearrangement 2995
Synthesis 2010, No. 17, 2990–2996 © Thieme Stuttgart · New York
carbamate products were isolated via the same simple workup as
described in the general procedure for ureas/carbamates 3.
Methyl (S)-2-{[(S)-1-(tert-Butoxycarbonylamino)-2-phenyleth-
yl]ureido}-3-methylbutanoate (Boc-Phe-y[NHCO]-Val-OMe, 
5c)
Yield: 334 mg (85%); white solid; mp 138–139 °C; Rf = 0.50
(CHCl3–MeOH, 9:1).
IR (KBr): 1644, 1690, 1726 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 0.93 (d, J = 5.8 Hz, 6 H), 1.35
(s, 9 H), 1.8 (m, 1 H), 2.85 (d, J = 7.2 Hz, 2 H), 3.63 (s, 3 H), 3.83–
3.93 (m, 2 H), 5.2 (br, 1 H), 6.35 (br, 1 H), 6.45 (d, J = 7.0 Hz, 1 H),
7.15–7.30 (m, 5 H).
13C NMR (75 MHz, DMSO-d6): d = 18.7, 19.5, 29.5, 37.1, 54.7,
57.5, 63.1, 78.2, 126.9, 127.6, 129.1, 137.9, 155.3, 156.9, 174.5.
HRMS: m/z [M + Na]+ calcd for C20H31N3O5: 416.2161; found:
461.2169.
Anal. Calcd for C20H31N3O5: C, 61.05; H, 7.94; N, 10.68. Found: C,
61.09; H, 7.98; N, 10.75.
Methyl (S)-2-{[(S)-4-Benzyloxy-1-(tert-butoxycarbonylamino)-
4-oxobutyl]ureido}-4-methylpentanoate {Boc-Glu(OBn)-
y[NHCO]-Leu-OMe, 5d}
Yield: 379 mg (79%); white solid; mp 139 °C; Rf = 0.4 (CHCl3–
MeOH, 9:1).
IR (KBr): 1656, 1702, 1742 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 0.91 (d, J = 4.8 Hz, 6 H), 1.32
(s, 9 H), 1.42 (m, 2 H), 1.65 (m, 1 H), 2.55 (m, 2 H), 2.92 (m, 2 H),
3.65 (s, 3 H), 3.81–3.92 (m, 2 H), 5.15 (s, 2 H), 5.33 (d, J = 4.7 Hz,
1 H), 6.35 (d,  J = 6.4 Hz, 1 H), 6.54 (d, J = 5.8 Hz, 1 H), 7.3–7.4
(m, 5 H).
13C NMR (75 MHz, DMSO-d6): d = 22.1, 23.1, 24.7, 28.6, 37.9,
39.7, 41.9, 50.9, 61.9, 63.1, 78.7, 126.7, 127.6, 128.9, 137.7, 155.3,
156.8, 157.5, 178.1.
HRMS: m/z [M + Na]+ calcd for C24H37N3O7: 502.2529; found:
502.2531.
Anal. Calcd for C24H37N3O7: C, 60.11; H, 7.78; N, 8.76. Found: C,
60.18; H, 7.73; N, 8.74.
2,4,5-Trichlorophenyl 1-[(9H-Fluoren-9-ylmethoxy)carbonyl-
amino]-2-phenylethylcarbamate (Fmoc-Phe-y[NHCO]-OTcp, 
6a)
Yield: 529 mg (91%); white solid; mp 142 °C; Rf = 0.35 (n-hexane–
EtOAc, 7:3).
IR (KBr): 1695, 1742 cm–1.
1H NMR (300 MHz, DMSO-d6): d = 2.85 (d, J = 6.2 Hz, 2 H), 3.81
(m, 1 H), 4.11 (t, J = 4.6 Hz, 1 H), 4.25 (d, J = 7.0 Hz, 2 H), 6.58
(br, 2 H), 7.23–8.15 (m, 15 H).
13C NMR (75 MHz, DMSO-d6): d = 38.9, 47.6, 52.5, 66.7, 120.0,
122.5, 124.6, 125.0, 127.1, 127.2, 127.8, 128.7, 129.1, 129.8, 132.0,
136.9, 141.2, 143.4, 151.4, 155.8, 156.6.
HRMS: m/z [M + Na]+ calcd for C30H23Cl3N2O4: 603.0621; found:
603.0626.
Anal. Calcd for C30H23Cl3N2O4: C, 61.92; H, 3.98; N, 4.81. Found:
C, 61.96; H, 3.95; N, 4.86.
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